Data generated in the genotyping assay is subsequently analyzed for mutations in the reverse transcriptase gene of HBV associated with resistance to therapeutic agents, and if identified an interpretation of their clinical significance provided.
This assay may not be successful when the HBV viral load is <500 IU/mL
Immediatley following collection, mix sample by inverting 5 times
Centrifuge sample within six hours of collection
Centrifuge sample within six hours of collection
Frozen (preferred) – 14 days
Refrigerated- not accepted
Ambient - not accepted
Polymerase chain reaction (PCR) amplification and DNA sequencing
An interpretive report will be provided